Notably, while our studies confirm the value of CXCL10 in the VEDOSS population, this is not a specific marker for SSc as increased levels of CXCL10 have been shown in SLE, DM as well as localized scleroderma [44–46]. Here, CXCL10 is linked to localized scleroderma.